PAM 1392 (2,4-diamino-6-(3,4-dichlorobenzylamino) quinazoline) as a chemotherapeutic agent: Plasmodium berghei, P. cynomolgi, P.
D000818:Animals; D000962:Antimalarials; D014355:Chagas Disease / Q000188:drug therapy*; D002642:Chick Embryo; D004032:Diet; D004357:Drug Synergism; D005260:Female; D000882:Haplorhini; D002955:Leucovorin / Q000037:antagonists & inhibitors; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D010965:Plasmodium malariae / Q000187:drug effects; D011799:Quinazolines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D013411:Sulfadiazine / Q000627:therapeutic use; D014345:Trypanosoma / Q000187:drug effects
D000962:Antimalarials; D011799:Quinazolines; D013411:Sulfadiazine; D002955:Leucovorin